Welcome back!
We recently returned from another inspiring
Patient Adherence Congress: A Frost & Sullivan One Day Executive Event. This year marked the 7th year of the Congress, and we continue to be excited by the wealth of information provided by the speakers and high level of attendee engagement and satisfaction.
This year’s Congress focused heavily on patient-centric medication adherence tactics, which we touched on in our recent assessment of adherence trends and which is explored further by our own
Sandra Nelson in this eBulletin. The event also included some timely public policy issues that may impact adherence, empirical data in support of co-pay discount offers, and the evolution of mobile adherence.
In this eBulletin, you will find articles surrounding:
- Frost & Sullivan’s 7th Annual Patient Adherence Congress Event Recap
- The Changing Face of the Healthcare Consumer
- Applying Adherence Research in the Real World
- Cross-cultural Adherence Insights
As thought leaders, we strive to bring forward and highlight an array of tools and knowledge that bring visibility to new and innovative ways to solve non-adherence. With that, we are pleased to pass along this latest edition of the Patient Adherence eBulletin. As your partner, we want to help keep you informed. If you have any questions, I encourage you to reach out to me.
Sincerely,
Greg Caressi
Senior Vice
President
Healthcare & Life Sciences
Frost & Sullivan
P.S. For the most up-to-date information regarding patient adherence, please visit the Frost & Sullivan
Patient Adherence
Events page. The
LinkedIn page
also allows you to receive updates for the 8th Annual Patient Adherence Congress in 2013.
|
|
| |
 |
Sandra Nelson
Senior Producer, Events Division
Frost & Sullivan
On March 8, 2012 over 60
executives from a variety of healthcare and pharmaceutical
companies met to discuss innovations and major developments in
patient adherence at Frost & Sullivan’s 7th Annual Patient
Adherence Congress at the Union League in Philadelphia held in
partnership with McKesson Patient Relations Solutions. >>more
|
|
|
|
|
 |
By Stacey Piluri
Marketing Communications Specialist
McKesson Patient Relationship Solutions
Adherence is a costly problem (estimated $290 billion), with both human and economic costs. Unnecessary hospital admissions, physician visits, and lab tests will continue to contribute to the rising cost of adherence while the industry reacts to an aging population of baby boomers and other key population shifts.
>>more
|
|
| |
|
|
|
Dr. Colleen
McHorney |
Interviewed by Frank Smith
Managing Editor, eBulletins
Frost & Sullivan
To highlight the market-wide shift in the healthcare industry
from boxed solutions to tailored engagement, Vitality displays
how manufacturers can reach patients through customized
messaging/outreach, health rewards/gaming and social networking.
>>more
|
|
| |
|
|
|
 |
By. Dirk G. Schroeder, ScD, MPH
HolaDoctor
HolaDoctor Inc has identified a number of effective ways to
engage Hispanics around health. These insights, combined with an
enormous shift by Hispanics to digital-and mobile-based
platforms for their health information needs, gives brand
managers some exciting new tools to engage this population.
>>more
|
|
| |
| |
|
|
|
|
|
|
|
|
|
|
 |
McKesson Patient Relationship Solutions is a unique division of McKesson Corporation created specifically to help pharmaceutical manufacturers build and expand their relationships with patients. Our core competency is delivering market leading acquisition and adherence solutions such as co-pay discounts, free trial offers, behavioral coaching, contact center services and pharmacy outreach.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
